Oxford Science Enterprises
Funding rounds backed by Oxford Science Enterprises.
- Funding disclosed in full
- $679.7M
- Median round
- $29.6M
- Rounds in calculation
- 7
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Vivid Dx Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions | $15MSeed | HealthtechUnited Kingdom | |||
| Mirae AI-driven continuous care platform for autoimmune disease and other complex chronic conditions | $5.4MSeed | HealthtechUnited Kingdom | 1 participantOxford Science Enterprises | ||
| Moa Technology An agricultural biotechnology company focused on discovering novel mode of action herbicides | £22.2MSeries C | AgritechUnited Kingdom | |||
| RQ Bio Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients | $115MSeries A | BiotechUnited Kingdom | |||
| Oxford Quantum Circuits Develops superconducting quantum computers delivered via cloud for financial services, defence, and research customers | £260MSeries C | HardwareUnited Kingdom | |||
| Quantum Motion Builds utility-scale quantum computers using industry-standard silicon transistors | $160MSeries C | HardwareUnited Kingdom | |||
| Allos AI Uses Causal AI to reformulate complex small-molecule drugs | $5MSeed | AIUnited States |